MedTrace Logo

Comparison of Pantoprazole and Ranitidine in Dyspepsia

NCT01737840 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2015-07-23

Study results available
· View outcomes & findings →

Summary

The H0 hypothesis of the study is there is no difference between pantoprazole and ranitidine in treating patients presented with dyspepsia to the emergency department.

The H1 hypothesis is there is difference between pantoprazole and ranitidine in treating patients presented with dyspepsia to the emergency department.

Conditions

  • Dyspepsia

Interventions

DRUG

Pantoprazole

33 patients

DRUG

Ranitidine

33 patients

Sponsors & Collaborators

  • Akdeniz University

    lead OTHER

Principal Investigators

  • Cenker Eken, Proffesor · Akdeniz University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01737840 on ClinicalTrials.gov